Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
TMCIthis companyTreace Medical Concepts, Inc.	$5.08	-2.63×	1.77×	0.73×	-3.67×	-250.0%	79.8%	-25.5%	-27.7%	-67.6%	-33.9%	-19.0%	0.16×	-0.08×	-10.18×	4.31×	0.0%	2	-0.04	1	D+
BVSBioventus Inc.	$10.87	21.88×	2.69×	0.87×	7.62×	-120.1%	67.3%	10.3%	4.0%	12.3%	10.8%	14.4%	1.69×	2.62×	2.21×	1.7×	0.0%	7	2.15	4	A-
CBLLCeriBell, Inc.	$27.59	-15.02×	5.16×	9×	-15.61×	-258.3%	87.9%	-65.6%	-60.0%	-34.4%	-32.9%	-5.2%	0.14×	0.36×	-30.9×	9.73×	0.0%	2	14.49	2	C+
EOLSEvolus, Inc.	$6.86	-8.31×	-18.55×	1.44×	-23.52×	27.2%	64.9%	-12.7%	-17.4%	223.5%	-24.6%	-11.8%	-6.71×	-4.49×	-1.91×	1.9×	0.0%	3	-1.44	2	C
KIDSOrthoPediatrics Corp.	$32.97	-10.51×	1.2×	1.76×	-41.17×	-243.9%	73.1%	-12.3%	-16.8%	-11.4%	-6.3%	-3.8%	0.29×	-6.66×	-4.84×	5.55×	0.0%	5	2.88	2	C
LABStandard BioTools Inc.	$0.69	-6.4×	1.15×	5.72×	-4.68×	-325.1%	49.9%	-109.3%	-87.8%	-17.7%	-12.2%	-16.9%	0.07×	1.02×	-3,588.65×	4.19×	0.0%	3	-0.44	2	C+
Peer median	—	-8.31×	1.2×	1.76×	-15.61×	-243.9%	67.3%	-12.7%	-17.4%	-11.4%	-12.2%	-5.2%	0.14×	0.36×	-4.84×	4.19×	0.0%	3	2.15	2	—